404

Not Found

Is this what you were looking for?

www jpeocbd osd mil
By Kelsey Kaustinen

Elusys Therapeutics receives anti-toxin contract

Biopharmaceutical company Elusys Therapeutics, Inc., which specializes in developing biodefense countermeasures, has announced that the U.S. government has awarded it a contract to develop an anti-toxin for pre-and post-exposure prophylaxis (PEP) use via intramuscular injection.

Run a Search

March 2024 Issue Front Cover

Latest Issue  

• Volume 20 • Issue 2 • March 2024

March 2024

March 2024 Issue